Giclinics Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U85100TG2019PTC137153 Incorporated 26 November 2019 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company healthcare DPIIT Startup MSME · Micro
Data last updated
Revenue · FY 2024
₹1.89 Cr
▲ 16% YoY
Net profit · FY 2024
₹8.85 Lakh
Net margin 4.7%
EBITDA · FY 2024
₹23.48 Lakh
EBITDA margin 12.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹30.18 Lakh
Issued & subscribed
Open charges
₹29.2 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
6
As per MCA filings

About Giclinics Private Limited

Data last updated:

Giclinics Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 26 November 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2019PTC137153.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹30.18 Lakh. It is led by directors including Priyanka Manne and Saikrishna Katepally.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.89 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹8.85 Lakh (net margin 4.7%) and EBITDA of ₹23.48 Lakh (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 282% over three years.

As per MCA filings, the company has open charges of ₹29.2 Lakh on record.

Giclinics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0058752).

Company details

CIN U85100TG2019PTC137153
Registration Number 137153
Incorporation Date 26 November 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0058752

Recognitions & Rankings of Giclinics

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-TS-02-0058752

Contact details

Giclinics Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Unit No. 201 Surya Arcade Behind Labonel Fine Baking, Cyberhills Colony P Janardhan Reddy Nagar, Hyderabad, Telangana, India – 500032
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Giclinics Private Limited, buy the company report.

Comprehensive company report
Giclinics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Giclinics is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Giclinics Private Limited, buy the company report.

Financials of Giclinics Private Limited

FY 2025 filings available

Giclinics Private Limited reported revenue of ₹1.89 Cr (up 16% YoY) for FY 2024.

Revenue · FY 2024
₹1.89 Cr ▲ 16%
Net profit · FY 2024
₹8.85 Lakh margin 4.7%
EBITDA · FY 2024
₹23.48 Lakh margin 12.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 282%
EBITDA CAGR growth
1 year
▲ 75%
3 years · compounded
▲ 356%

Revenue has grown at a compounded annual rate (CAGR) of 282% over three years, including 16% growth in the latest year. EBITDA rose 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹23.48 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8.85 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin12.5%
Net Profit Margin4.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Giclinics Private Limited, buy the company report.

Board of directors of Giclinics Private Limited

Giclinics has 6 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Priyanka ManneDirector26 Nov 20196 Years 11 MonthsCurrent
Saikrishna KatepallyDirector26 Nov 20196 Years 11 MonthsCurrent
Babireddy Sivananda ReddyDirector17 Nov 20205 Years 11 MonthsCurrent
Rohan Reddy ProddutoorDirector26 Nov 20196 Years 11 MonthsCurrent
Mudumala Issac AbhilashDirector26 Nov 20196 Years 11 MonthsCurrent
Kiran Kumar PeddiDirector17 Nov 20205 Years 11 MonthsCurrent

Auditor

Giclinics Private Limited is audited by S K KAPARTI & CO for the financial year 2021.

Auditor firmFinancial yearFirm registration number
S K KAPARTI & COFY 2021001742S

Shareholding

The shareholding of Giclinics Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Giclinics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹29.2 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.29 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Oct 2024100995133Others₹19.2 LakhOpen
29 Feb 2024100895591Others₹10 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Giclinics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Giclinics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Giclinics Private Limited has 6 board changes on record since 2019: 6 appointments. The latest: Babireddy Sivananda Reddy was appointed as Director on 17 Nov 2020.

AGM
Giclinics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Giclinics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 19.20 Lakh with Charge ID 100995133 was registered on 29 Oct 2024.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100895591 was registered on 29 Feb 2024.
Appointed
Babireddy Sivananda Reddy was appointed as Director.
Appointed
Kiran Kumar Peddi was appointed as Director.
Appointed
Mudumala Issac Abhilash was appointed as Director.
Appointed
Priyanka Manne was appointed as Director.
Appointed
Rohan Reddy Proddutoor was appointed as Director.
Appointed
Saikrishna Katepally was appointed as Director.
Incorporation
26 Nov 2019
Giclinics Private Limited was registered on 26 Nov 2019 with Roc Hyderabad & aged 6 years 11 months as per MCA records.

Frequently asked questions

Giclinics is an active private limited company based in Hyderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 26 November 2019 (7+ years old) and is registered under CIN U85100TG2019PTC137153.

Giclinics has 6 current directors:

The latest financial statements of Giclinics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The CIN (Corporate Identification Number) of Giclinics is U85100TG2019PTC137153. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Giclinics was incorporated on 26 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.

Babireddy Sivananda Reddy was appointed as Director on 17 Nov 2020. Kiran Kumar Peddi was appointed as Director on 17 Nov 2020. Mudumala Issac Abhilash was appointed as Director on 26 Nov 2019. Giclinics has 6 board changes on record in total.

Yes, Giclinics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Giclinics is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0058752).

The registered office of Giclinics is at Unit No. 201 Surya Arcade Behind Labonel Fine Baking, Cyberhills Colony P Janardhan Reddy Nagar, Hyderabad, Telangana, India – 500032.

Giclinics operates in the healthcare industry, in the preventive health services segment.